Literature DB >> 11695876

General pharmacological properties of Sho-seiryu-to (TJ-19) extracts.

S Amagaya1, A Iizuka, B Makino, M Kubo, Y Komatsu, F C Cheng, T I Ruo, T Itoh, K Terasawa.   

Abstract

The general pharmacological properties of TJ-19 extracts were orally investigated in various experimental animals. TJ-19 extracts showed no effect on general behavior and on central nervous system such as spontaneous locomotor activity, proconvulsant and anti-convulsant responses, analgesic activity, body temperature and hexobarbital sleeping time at all doses of 0.5, 1 and 2 g/kg in mice. Further, TJ-19 extracts showed no effect on contractile responses of isolated guinea pig ileum induced by acetylcholine, histamine and BaCl2 at concentrations of 10(-6), 10(-5), and 10(-4) g/ml. TJ-19 extracts, however, increased the respiratory rate, heart rate, blood pressure, systolic pressure, diastolic pressure, and decreased the blood flow in dogs at all doses of 0.5, 1 and 2 g/kg via duodenal administration. Further, TJ-19 extracts decreased the interval of PR and QT of EKG parameters in dogs at doses of 1 and 2 g/kg. TJ-19 extracts increased the intestinal transport of charcoal meal in rats at doses of 1 and 2 g/kg. TJ-19 increased the urinary Na+ excretion at all doses of 0.5, 1, and 2 g/kg, and increased the urinary K+ and Cl- excretion at 1 and 2 g/kg, although it showed no effect on urine volume output in rats. These data suggest that TJ-19 stimulates the sympathetic nervous system function at a pharmacological dose of under 0.5 g/kg, and has possibility to increase the intestinal peristalsis and urinary electrolyte excretion at higher doses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11695876     DOI: 10.1078/0944-7113-00061

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6.

Authors:  Masashi Nakao; Yousuke Muramoto; Motoko Hisadome; Naoko Yamano; Mami Shoji; Yumi Fukushima; Junji Saruwatari; Kazuko Nakagawa
Journal:  Eur J Clin Pharmacol       Date:  2007-02-13       Impact factor: 2.953

2.  Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Authors:  Qinglin Zha; Seqi Lin; Chi Zhang; Christopher Chang; Hanrong Xue; Cheng Lu; Miao Jiang; Yan Liu; Zuke Xiao; Weiyou Liu; Yunfei Shang; Jianjian Chen; Minyong Wen; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-03       Impact factor: 2.629

3.  DNA microarrays in herbal drug research.

Authors:  Preeti Chavan; Kalpana Joshi; Bhushan Patwardhan
Journal:  Evid Based Complement Alternat Med       Date:  2006-10-27       Impact factor: 2.629

4.  In Vitro Anti-Cytomegalovirus Activity of Kampo (Japanese Herbal) Medicine.

Authors:  Tsugiya Murayama; Nobuo Yamaguchi; Hideo Matsuno; Yoshito Eizuru
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-27       Impact factor: 2.629

5.  So-Cheong-Ryong-Tang, a herbal medicine, modulates inflammatory cell infiltration and prevents airway remodeling via regulation of interleukin-17 and GM-CSF in allergic asthma in mice.

Authors:  Hyung-Woo Kim; Chi-Yeon Lim; Bu-Yeo Kim; Su-In Cho
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

6.  Xiao-Qing-Long Tang Prevents Cardiomyocyte Hypertrophy, Fibrosis, and the Development of Heart Failure with Preserved Ejection Faction in Rats by Modulating the Composition of the Gut Microbiota.

Authors:  Guo-Feng Zhou; Yue-Hua Jiang; Du-Fang Ma; Yong-Cheng Wang; Jin-Long Yang; Ji-Ye Chen; Chen-Yu Chi; Xiao-Wei Han; Zhao-Yu Li; Xiao Li
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

7.  Dynamic Microbial Shifts and Signatures of Long-Term Remission in Allergic Rhinitis After an Herbal Formula Treatment.

Authors:  Libing Zhu; Yuning Wu; Chenglong Lin; Lin Tang; Bin Yu; Wenrong Wan; Jingxiu Xuan; Yanling Du; Zhangran Chen; Wei Liang
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.